BAK vs WLK vs CC Stock Comparison

Braskem, Westlake and Chemours Prices as of Nov 13, 2026 Peers: Industry group
1 more company in this comparison (CE) Create a free account to keep reading and compare up to 10 companies.
BAK Braskem Sa
$1.14 -38.0% 1M -58.8% 1Y
Market cap
$754.88M
P/E
–
Revenue (TTM)
—
Div. yield
–
Commodity Chemicals Basic Materials
1 win
WLK Westlake Corp
$63.63 +2.3% 1M -2.0% 1Y
Market cap
$7.87B
P/E
–
Revenue (TTM)
$11.44B
Div. yield
0.03%
Commodity Chemicals Basic Materials
5 wins
CC Chemours Co
$13.28 +3.3% 1M +8.2% 1Y
Market cap
$1.89B
P/E
–
Revenue (TTM)
$5.84B
Div. yield
0.03%
Commodity Chemicals Basic Materials
5 wins

Head to Head

11 decided of 12

Westlake leads on 5 of the 12 questions below (Westlake 5, Chemours 5, Braskem 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBAKWLKCCLeader
Larger companyMarket capitalisation $754.88M $7.87B $1.89B WLK
Cheaper on earningsLower P/E, profitable companies only -0.5x -17.6x -12.3x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 2.1x 43.0x 15.1x BAK
Faster revenue growthRevenue growth, trailing twelve months — -0.4% +0.1% CC
More profitableNet margin, trailing twelve months — -3.9% -2.6% CC
Better return on capitalReturn on invested capital — -2.4% 0.0% CC
Less leveragedLower net debt / EBITDA — 4.3x 8.6x WLK
Higher dividend yieldTrailing dividend yield 0.00% 0.03% 0.03% WLK
Better 1-year returnPrice return, last 12 months -58.8% -2.0% +8.2% CC
Better 5-year returnAnnualised price return, 5 years -42.3%/yr -9.5%/yr -16.7%/yr WLK
Less volatileAnnualised volatility, 1 year 94.6% 42.9% 61.9% WLK
Higher overall scoreMean of the five percentile scores vs peers — 47/100 49/100 CC

Percentile Scorecard

BAKWLKCC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBAKWLKCC
Valuation 26 #71 of 96 60 #39 of 96 57 #42 of 96
Growth – 26 #68 of 92 88 #12 of 92
Profitability – 31 #62 of 89 41 #53 of 89
Financial Health 6 #90 of 96 45 #53 of 96 18 #79 of 96
Shareholder Returns – 71 #24 of 79 40 #48 of 79
Overall – 47 49
  • BAK ranked among 99 companies in Chemicals
  • WLK ranked among 99 companies in Chemicals
  • CC ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBAKWLKCCSPY
1 month -38.0%+2.3%+3.3% -2.0%
3 months -41.5%-20.0%-16.2% -2.8%
6 months -76.7%-28.2%-42.6% +2.0%
Year to date -61.4%-13.9%+12.6% +10.6%
1 year -58.8%-2.0%+8.2% +12.2%
3 years -86.1%-51.0%-50.5% +68.1%
3 years, per year -48.2%-21.2%-20.9% +18.9%
5 years -93.6%-39.1%-60.0% +61.4%
5 years, per year -42.3%-9.5%-16.7% +10.1%
10 years -93.2%+19.9%-35.9% +248.5%
10 years, per year -23.5%+1.8%-4.3% +13.3%

Risk

MeasureBAKWLKCCSPY
Volatility, 1Y 94.6%42.9%61.9% 13.6%
Downside volatility, 1Y 102.7%37.3%68.2% 13.9%
Beta vs S&P 500, 1Y 1.290.381.45 1.00
Return / volatility, 1Y -0.62-0.050.13 0.90
Max drawdown, 5Y -95.5%-65.2%-79.0% -25.4%
From 52-week high -77.3%-48.4%-52.5% -3.2%
52-week high $5.02$123.39$27.94 $779.14
52-week low $1.06$56.38$10.48 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBAKWLKCC
P/E now vs peer median -0.5xmedian 23.4x -18.2xmedian 23.4x -13.0xmedian 23.4x
P/S now vs peer median 0.1xmedian 1.3x 0.7xmedian 1.3x 0.3xmedian 1.3x
EV/EBITDA now vs peer median —median 12.7x 15.6xmedian 12.7x 14.0xmedian 12.7x
P/FCF now vs peer median -0.7xmedian 17.0x 678.1xmedian 17.0x 9.5xmedian 17.0x
P/B now vs peer median -0.3xmedian 1.5x 0.9xmedian 1.5x 12.8xmedian 1.5x
PEG now vs peer median —median 1.72 0.55median 1.72 -0.60median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBAKWLKCC
Revenue – $11.44B $5.84B
Gross profit – $1.23B $885.00M
Operating income – -$436.00M $37.00M
Net income – -$412.00M -$154.00M
Free cash flow – $12.00M $211.00M
R&D – – $104.00M
EPS (diluted) – $-3.49 $-1.01
Cash & equivalents $1.92B $1.76B $698.00M
Total debt $9.79B $5.06B $3.83B
Shares (diluted) 797.21M 127.96M 151.91M
Enterprise value -$9.55B -$1.36B -$711.88M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBAKWLKCC
P/E -0.5x -18.2x -13.0x
P/FCF -0.7x 678.1x 9.5x
P/Operating cash flow – 9.6x 5.0x
P/S 0.1x 0.7x 0.3x
P/B -0.3x 0.9x 12.8x
P/Tangible book -0.3x 1.0x 13.0x
EV/EBITDA – 15.6x 14.0x
EV/EBIT – -25.8x 138.8x
EV/Revenue – 1.0x 0.9x
EV/FCF – 935.9x 24.3x
EV/Operating cash flow – 13.3x 12.8x
PEG (3Y EPS CAGR) – 0.55 -0.60

Growth

14 metrics
MetricBAKWLKCC
Revenue growth (1Y) – -0.4% 0.1%
Revenue CAGR (3Y) – -4.2% -1.2%
Gross profit growth (1Y) – 17.0% -12.5%
Gross profit CAGR (3Y) – -21.9% -10.9%
Operating income growth (1Y) – 48.2% 1,133%
Operating income CAGR (3Y) – -31.4% 29.0%
Net income growth (1Y) – 55.7% 55.9%
Net income CAGR (3Y) – -32.5% 21.3%
EPS growth (1Y) – 53.2% 56.3%
EPS CAGR (3Y) – -33.4% 21.6%
Operating cash flow growth (1Y) – 25.2% 50.9%
Operating cash flow CAGR (3Y) – -31.3% 19.4%
Free cash flow growth (1Y) – 103.3% 1,858%
Free cash flow CAGR (3Y) – -80.2% 72.7%

Profitability

14 metrics
MetricBAKWLKCC
Gross margin – 10.8% 15.2%
EBITDA margin – 6.3% 6.3%
Operating margin – -3.8% 0.6%
Pretax margin – -4.4% 2.3%
Net margin – -3.9% -2.6%
FCF margin – 0.1% 3.6%
Operating cash flow margin – 7.4% 6.8%
Return on equity – -4.4% -285.2%
Return on assets – -2.1% -2.1%
Return on invested capital – -2.4% 0.0%
Return on capital employed – -2.6% 0.7%
Asset turnover – 0.6x 0.8x
Cash conversion (OCF / net income) – -2.0x -2.6x
Stock comp / revenue – 0.4% 0.4%

Financial Health

11 metrics
MetricBAKWLKCC
Debt / assets 65.5% 26.3% 52.6%
Debt / equity -3.2x 0.6x 24.6x
Net debt / EBITDA – 4.3x 8.6x
Debt / FCF – 422.0x 18.2x
Liabilities / assets 120.2% 52.5% 97.9%
Equity / assets -20.2% 47.5% 2.1%
Interest coverage – -2.0x 0.1x
Current ratio 0.8x 2.4x 1.8x
Quick ratio 0.5x 1.6x 0.9x
Cash ratio 0.3x 0.8x 0.4x
Altman Z-score – 1.83 1.43

Shareholder Returns

7 metrics
MetricBAKWLKCC
Dividend yield – 3.3% 2.7%
Net buyback yield – 0.8% -0.2%
Shareholder yield 0.0% 4.1% 2.5%
Payout ratio (earnings) – -66.3% -35.1%
Payout ratio (FCF) – 2,275% 25.6%
Dividend growth (1Y) – 0.7% -45.5%
Dividend CAGR (3Y) – 10.6% -28.7%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBAKWLKCC
Forward P/E 2.1xFY2026 43.0xFY2026 15.1xFY2026
EPS, next fiscal year $0.54FY2026 $1.48FY2026 $0.88FY2026
EPS growth, next FY – – -7.4%FY2026
EPS growth, the year after -313.0% +10.1% +109.1%
Revenue, next fiscal year $14.98BFY2026 $12.12BFY2026 $5.76BFY2026
Revenue growth, next FY +7.3%FY2026 +8.5%FY2026 -0.9%FY2026
Revenue growth, the year after -1.1% -4.9% +2.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBAKWLKCC
Held by institutions 2.3% 31.0% 89.4%
Institutions holding 63 364 472
Change in shares held, QoQ +157.7% -9.9% +2.8%
Institutions buying 32 198 213
Institutions selling 16 118 127
Buyers to sellers 2.00 1.68 1.68

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BAKWLKCC
BAK 1.00 0.20 0.19
WLK 0.20 1.00 0.45
CC 0.19 0.45 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BAK, WLK and CC?

Westlake (WLK) is the largest by market capitalisation: Braskem (BAK) $754.88M, Westlake (WLK) $7.87B, Chemours (CC) $1.89B.

Which company is growing faster?

Chemours (CC) grew revenue fastest over the trailing twelve months: Westlake (WLK) -0.4%, Chemours (CC) +0.1%.

Which company is more profitable?

Chemours (CC) has the highest net margin (Westlake (WLK) -3.9%, Chemours (CC) -2.6%). On return on invested capital, Chemours (CC) leads (Westlake (WLK) -2.4%, Chemours (CC) 0.0%).

Which stock has performed better?

Over the past year Chemours (CC) returned the most: Braskem (BAK) -58.8%, Westlake (WLK) -2.0%, Chemours (CC) +8.2%. Over five years, Westlake (WLK) compounded fastest (Braskem (BAK) -42.3%/yr, Westlake (WLK) -9.5%/yr, Chemours (CC) -16.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Westlake (WLK) has the highest dividend yield: Braskem (BAK) 0.00%, Westlake (WLK) 0.03%, Chemours (CC) 0.03%. Braskem (BAK) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Westlake (WLK) has been the steadiest (Braskem (BAK) 94.6%, Westlake (WLK) 42.9%, Chemours (CC) 61.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BAK, WLK and CC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Westlake (WLK) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.